GlassScriptPhysician profile
Daniel R Denis
NPI 1184031627
$197,768.73
in general payments reported to CMS, 2019-2025
26 companies · $3,190 in 2025
The $3,190 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $31K · 2021: $38K · 2022: $58K · 2023: $39K · 2024: $9,747 · 2025: $3,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,775 · Food and Beverage: $4,921 · Travel and Lodging: $2,877 · Royalty Or License: $2,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,775.00 |
| Food and Beverage | $4,920.79 |
| Travel and Lodging | $2,876.73 |
| Royalty Or License | $2,658.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $116,365.64 | 2019-2025 | Corbel, Mars Anterior Retractor, Mars 3v/3vl |
| Medical Device Business Services, INC. | $42,354.02 | 2021-2024 | |
| Si-Bone, INC. | $20,397.34 | 2019-2025 | |
| Abbott Laboratories | $11,039.03 | 2022-2025 | Proclaim, Eterna |
| Zimvie INC. | $1,643.93 | 2022 | |
| Aesculap Implant Systems, LLC | $987.76 | 2022 | |
| Relievant Medsystems, INC. | $930.71 | 2022 | |
| Depuy Synthes Sales INC. | $809.43 | 2020-2025 | Conduit, Acis, Viper |
| Alon Medical Technology | $648.40 | 2025 | |
| Spinal Simplicity, LLC | $584.57 | 2022-2025 | Ha Minuteman G3-R |
| Nevro Corp. | $283.16 | 2019-2023 | Senza |
| Spine Wave, INC. | $279.26 | 2019 | |
| Brainlab, INC. | $259.86 | 2022 | |
| Alphatec Spine, INC | $224.02 | 2019-2022 | |
| Arthrex, INC. | $209.95 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $186.25 | 2022 | |
| Medtronic, INC. | $150.10 | 2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Kyphon Express II Kyphopak Tray, Pivox Oblique Lateral Spinal System |
| Boston Scientific Corporation | $127.37 | 2019-2021 | |
| Providence Medical Technology, INC. | $62.72 | 2022 | |
| Cerapedics INC. | $60.31 | 2020-2024 | I-Factor Peptide Enhanced Bone Graft |
| Saluda Medical Americas, INC. | $57.83 | 2023 | Evoke Scs |
| Lilly USA, LLC | $35.86 | 2024-2025 | Kisunla, Amyvid |
| Lundbeck LLC | $20.19 | 2024 | Vyepti |
| Bioventus LLC | $19.01 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.58 | 2025 | |
| Tanabe Pharma America, INC. | $15.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Denis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.